Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs)
$106.09
neg -0.58
-0.54%
Today's Range: 104.08 - 107.00 | GILD Avg Daily Volume: 14,285,000
Last Update: 10/22/14 - 4:00 PM EDT
Volume: 13,668,014
YTD Performance: 42.04%
Open: $106.51
Previous Close: $106.67
52 Week Range: $63.50 - $110.64
Oustanding Shares: 1,511,670,456
Market Cap: 154,507,837,308
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 13
Moderate Buy 2 1 1 1
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.33 1.33 1.31
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 23.02
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
23.02 23.00 27.46
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
20.04% 59.23% 414.44%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.50 0.41 0.12
Net Income 18.80 0.06 0.02
EPS 10.80 0.18 0.06
Earnings for GILD:
EBITDA 4.87B
Revenue 11.20B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.64 $2.22 $7.26 $9.07
Number of Analysts 3 3 3 3
High Estimate $1.85 $2.81 $8.34 $10.13
Low Estimate $1.35 $1.52 $5.51 $7.31
Prior Year $0.50 $0.52 $1.92 $7.26
Growth Rate (Year over Year) 227.33% 326.28% 278.30% 24.83%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Oct 21, 2014 | 1:28 PM EDT

Welcome back to the airlines and the biotechs.

By

David Katz

 | Oct 21, 2014 | 12:30 PM EDT

Investing during a mid-term election can offer large returns.

By

David Katz

 | Oct 17, 2014 | 10:00 AM EDT

There is a disconnect between stock prices and intrinsic value.

By

Bret Jensen

 | Oct 17, 2014 | 8:35 AM EDT

Of course, I remain concerned about the massive impact that central bankers' words continue to have.

By

Bret Jensen

 | Oct 16, 2014 | 10:00 AM EDT

I'm taking the emotions out of my trading.

By

Jim Cramer

 | Oct 14, 2014 | 10:55 AM EDT

Because it's completely hit or miss.

By

Carolyn Boroden

 | Oct 8, 2014 | 9:00 AM EDT

Odds are up for a bounce.

By

Bret Jensen

 | Oct 2, 2014 | 11:00 AM EDT

It's the logical play, as the market could have more possible downside than upside in the near term.

By

Bret Jensen

 | Sep 29, 2014 | 11:30 AM EDT

With volatility on the rise, watch out for these issues.

By

Gary Dvorchak

 | Sep 26, 2014 | 9:00 AM EDT

My strategy for when markets get choppy.

The major market indices continue to move within the parameters of the Fibonacci retraceme...
Since we cleared a key decision on the way up, I want to watch this pullback for an entry ...
Conclusion DDD is down today on new that the firm has cut revenue forecast due to producti...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.